Welcome - TB (Mesh-Project)

Project Report: Science-2-Society: Raising future leaders in high schools in South Africa

Immunologist Lerato Ndlovu shares her experience of using a play and career talks in a project, supported by the DELTAS Africa CPE Seed Fund, to engage high school pupils in rural South African communities with research and increase their scientific understanding of TB and its treatment.

Project Report: The Silent Plague: raising awareness of antibiotic-induced hearing loss in Nigeria

In this article, Dr Adebolajo Adeyemo describes his community and public engagement project, supported by the DELTAS Africa CPE Seed Fund, in which he aimed to raise awareness of aminoglycoside-induced hearing loss through the creation of a Nollywood movie, in Nigeria.

Project Report: Scrutinized: Harnessing adolescence advocacy to end TB in Botswana

This project from Botswana-Harvard AIDS Institute Partnership, supported by the DELTAS Africa CPE Seed Fund, used storytelling and film to explore perceptions and attitudes to HIV/TB in schools in Gaborone, Botswana

Webinar: Public Engagement and Involvement in Health Research: How well are we doing?

In these videos, from a webinar delivered in July 2020 as part of the Cochrane Learning Live and International PPI Network webinar series, you will hear from speakers in the UK and South Africa who share their experiences of the positive aspects of engagment as well as putting forward the problems and issues within the field.

Project Report: Eh!woza: Intersection of Art and Science to Engage Youth around Tuberculosis

Project Report: The Lucky Specials

Project Report: The Lucky Specials and public engagement in the post-truth era

Mwangi Chege, participant of the 2017 Wellcome Trust workshop "It’s Complicated: navigating scientific complexity in public and community engagement" reflects on learning from the workshop. In particular, the Kenyan premiere of The Lucky Specials, a feature film designed as both entertainment and engagement with audiences about Multi-Drug Resistant Tuberculosis and the importance of drug adherence.